We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$24.6B
AUM Growth
-$539M
Cap. Flow
-$2.74B
Cap. Flow %
-11.15%
Top 10 Hldgs %
16.61%
Holding
1,387
New
97
Increased
426
Reduced
465
Closed
225

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$66.4M
2
MSFT icon
Microsoft
MSFT
+$52.8M
3
MA icon
Mastercard
MA
+$39.5M
4
LIN icon
Linde
LIN
+$28.7M
5
RACE icon
Ferrari
RACE
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 25.11%
2 Healthcare 16.99%
3 Financials 12.25%
4 Consumer Discretionary 11.39%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZWS icon
476
Zurn Elkay Water Solutions
ZWS
$8.55B
$8.17M 0.03%
+520,038
New +$7.48M
CROX icon
477
Crocs
CROX
$6.63B
$8.16M 0.03%
194,900
-22,700
-10% -$793K
SRPT icon
478
Sarepta Therapeutics
SRPT
$1.64B
$8.12M 0.03%
62,956
+1,470
+2% +$148K
JKHY icon
479
Jack Henry & Associates
JKHY
$11.4B
$8.08M 0.03%
55,465
+11,200
+25% +$1.64M
MAN icon
480
ManpowerGroup
MAN
$2.6B
$8.06M 0.03%
82,978
-44,723
-35% -$4.09M
LVS icon
481
Las Vegas Sands
LVS
$31.4B
$8.03M 0.03%
116,370
+5,356
+5% +$334K
HLT icon
482
Hilton Worldwide
HLT
$72.4B
$8.02M 0.03%
72,300
-29,700
-29% -$2.98M
EQC
483
DELISTED
Equity Commonwealth
EQC
$7.99M 0.03%
+243,219
New +$7.82M
NBIX icon
484
Neurocrine Biosciences
NBIX
$18.2B
$7.96M 0.03%
+74,092
New +$7.76M
LM
485
DELISTED
Legg Mason, Inc.
LM
$7.91M 0.03%
220,200
-4,700
-2% -$174K
NDAQ icon
486
Nasdaq
NDAQ
$53.4B
$7.78M 0.03%
217,791
+104,742
+93% +$3.57M
KIM icon
487
Kimco Realty
KIM
$17.5B
$7.67M 0.03%
370,262
+129,097
+54% +$2.71M
LAD icon
488
Lithia Motors
LAD
$9.75B
$7.66M 0.03%
52,100
+1,700
+3% +$255K
MORN icon
489
Morningstar
MORN
$7.55B
$7.66M 0.03%
50,604
+33,904
+203% +$5.21M
BLDR icon
490
Builders FirstSource
BLDR
$7.29B
$7.63M 0.03%
300,200
+228,200
+317% +$5.45M
TXMD icon
491
TherapeuticsMD
TXMD
$23.8M
$7.57M 0.03%
62,587
YEXT icon
492
Yext
YEXT
$573M
$7.57M 0.03%
525,122
+1,496
+0.3% +$23.2K
BCE icon
493
BCE
BCE
$20.8B
$7.52M 0.03%
162,301
-9,100
-5% -$436K
EPR icon
494
EPR Properties
EPR
$4.89B
$7.42M 0.03%
105,109
+6,600
+7% +$487K
IEX icon
495
IDEX
IEX
$17B
$7.41M 0.03%
43,096
+3,665
+9% +$593K
TNDM icon
496
Tandem Diabetes Care
TNDM
$1.27B
$7.41M 0.03%
124,354
+94,516
+317% +$5.83M
SO icon
497
Southern Company
SO
$108B
$7.41M 0.03%
116,296
-76,302
-40% -$4.73M
BRKR icon
498
Bruker
BRKR
$9.4B
$7.29M 0.03%
143,000
-10,200
-7% -$486K
CNA icon
499
CNA Financial
CNA
$14.9B
$7.29M 0.03%
162,652
-80,269
-33% -$3.62M
PBF icon
500
PBF Energy
PBF
$7.49B
$7.28M 0.03%
232,200
+156,800
+208% +$4.82M

Similar funds

Axa's Q4 2019 Portfolio in Review

As of Q4 2019, Axa held 1,387 positions worth $24.6B, down 2.1% from $25.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Axa withdrew a net $2.74B in Q4 2019, closing 225 positions and reducing 465 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $160M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in Baker Hughes worth $26.1M.

  • Axa's largest Q4 2019 buy was Baker Hughes: 1,017,347 shares worth $26.1M.
  • Axa added most to Pfizer in Q4 2019, an estimated $66.4M increase.
  • Axa's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $89.1M.
  • Axa fully exited iShares Russell 1000 Growth ETF in Q4 2019, selling an estimated $160M.
  • Axa's ten largest holdings make up 17% of its $24.6B portfolio in Q4 2019.
  • Axa opened 97 new positions and closed 225 in Q4 2019.
  • Axa's portfolio value fell 2.1% quarter-over-quarter to $24.6B.

Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.